Alan Scott, CEO for the Biosecurity Group, has had more than 30 years’ experience in business management. This experience includes international and Australian Funds Management dealing directly with many international investment banks and stockbrokers He has held management roles with of a number of developing companies, including Managing Director and Chairmanship roles with biotechnology companies.
Alan has managed pre-clinical animal models for a wide range of diseases, together with human clinical trials related to cancer, rheumatoid arthritis and psoriasis in the US, Europe and Australia, as well as patent grants and USFDA GMP plant accreditation. These roles involved direct contact with many large pharmaceutical and biotechnology companies.